Group structure
10 companies in 5 countries
Loading your page…
Loading your page…
10 companies in 5 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
24 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CLEAR EYES0.012 % · Liquid | Naphazoline | Canada | Marketed | 2004 |
| CLEAR EYES ALLERGY0.26 % + 0.012 % + 0.25 % · Liquid | Glycerine, Naphazoline, Zinc | Canada | Marketed | 2004 |
| CLEAR EYES EXTRA STRENGTH REDNESS RELIEF0.50 % / w/v + 0.03 % / w/v · Solution | Glycerine, Naphazoline | Canada | Marketed | 2011 |
| CLEAR EYES TRIPLE ACTION RELIEF0.5 % + 0.6 % + 0.05 % · Solution | Polyvinyl alcohol, Povidone, Tetryzoline | Canada | Marketed | 2008 |
| MURINE5 mg / ml + 6 mg / ml · Solution | Polyvinyl alcohol, Povidone | Canada | Marketed | 2004 |
| SLEEP-EZE25 mg · Tablet | Diphenhydramine | Canada | Marketed | 2010 |
| TUZNUEPolvere per concentrato per soluzione per infusione | Trastuzumab | Italy | Authorised | |
| Tuznue | Trastuzumab | EU (EMA) | Authorised | 2024 |
| Tuznue 150 mg poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie | Trastuzumab | Netherlands | Authorised | 2024 |
| Tuznue 420 mg poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie | Trastuzumab | Netherlands | Authorised | 2024 |
| CHILDREN'S LITTLE REMEDIES FOR FEVERS160 mg / 5 ml · Solution | Paracetamol | Canada | Cancelled | 2012 |
| CLEAR EYES FOR DRY EYES1.0 % + 0.25 % · Solution | Carboxymethylcellulose, Glycerine | Canada | Cancelled | 2008 |
| CLEAR EYES FOR DRY EYES PLUS REDNESS RELIEF0.25 % + 0.8 % + 0.012 % · Solution | Glycerine, Hypromellose, Naphazoline | Canada | Cancelled | 2008 |
| Hervelous | Trastuzumab | EU (EMA) | Refused | |
| INFANTS LITTLE REMEDIES FOR FEVERS80 mg / ml · Drops | Paracetamol | Canada | Cancelled | 2012 |
| LITTLE COLDS DECONGESTANT PLUS COUGH5 mg / ml + 2.5 mg / ml · Liquid | Dextromethorphan, Phenylephrine | Canada | Cancelled | 2007 |
| LITTLE COLDS MULTI-SYMPTOM COLD FORMULA80 mg / ml + 2.5 mg / ml + 1.25 mg / ml · Liquid | Paracetamol, Dextromethorphan, Phenylephrine | Canada | Cancelled | 2007 |
| LITTLE NOSES DECONGESTANT NOSE DROPS0.125 % · Liquid | Phenylephrine | Canada | Cancelled | 2007 |
| LITTLE TUMMYS GAS RELIEF DROPS20 mg / 0.3 ml · Liquid | Dimethicone | Canada | Cancelled | 2007 |
| NEO-ZOL CREAM 1%1 % / w/w · Cream | Clotrimazole | Canada | Cancelled | 1990 |
| NEO-ZOL VAGINAL CREAM 1%1 % / w/w · Cream | Clotrimazole | Canada | Cancelled | 1990 |
| NEO-ZOL VAGINAL CREAM 2%2 % / w/w · Cream | Clotrimazole | Canada | Cancelled | 1990 |
| PRESTIGE LIGHT RESPONSE4 % + 2 % · Liquid | Octinoxate, Oxybenzone | Canada | Cancelled | 2005 |
| Tuznue | Trastuzumab | EU (EMA) | Refused |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 18 | 6 | 12 | CompaniesAll medicines |
| European Union (EMA) | 3 | 1 | 2 | CompaniesAll medicines |
| Netherlands | 2 | 2 | 0 | CompaniesAll medicines |
| Italy | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, Croatia, Serbia, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.